Evidence map›Paper›PMID 15481444›Full record

ArticleInternational journal of hematology2004

Fluorescent in situ hybridization analysis of Philadelphia chromosome-negative chronic myeloid leukemia with the bcr/abl fusion gene.

Fumihiko Monma, Kazuhiro Nishii, Shunji Yamamori, Noboru Hosokai, Takahiro Nakazaki, Felipe Lorenzo, Eiji Usui, Miho Sakakura, Hiroyuki Miyashita, Atsushi Fujieda and 3 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Fumihiko MonmaSecond Department of Internal Medicine, Mie University School of Medicine, Tsu, Mie, Japan.
Kazuhiro Nishii
Shunji Yamamori
Noboru Hosokai
Takahiro Nakazaki
Felipe Lorenzo
Eiji Usui
Miho Sakakura
Hiroyuki Miyashita
Atsushi Fujieda
Kohshi Ohishi
Naoyuki Katayama
Hiroshi Shiku
Mie University · JPMitsubishi Group (Japan) · JPNoguchi Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes a patient with Philadelphia chromosome-negative (Ph-) but bcr/abl fusion gene-positive chronic myeloid leukemia (CML) and a molecular analysis of the mechanisms behind the Ph status. Spectral karyotyping-fluorescent in situ hybridization (SKY-FISH) analysis showed no abnormal translocation; however, a bcr/abl fusion gene was detected by reverse transcriptase-polymerase chain reaction analysis. FISH analysis showed that signals from the 9q and 22q subtelomere probes were detected on the der(9) and der(22) chromosomes, respectively. On the other hand, FISH analysis of the abl and bcr genes with dual fusion probes, which can detect the bcr/abl fusion gene on both the der(9) and der(22) chromosomes, showed the signal for bcr/abl fusion on the der(22) chromosome but not on the der(9) chromosome. These results indicate that insertion of the abl gene into the bcr region on the der(22) chromosome or retranslocation between the der(9) chromosome and the der(22) chromosome may have caused the Ph CML in this case.

Indexed as

AdultFemaleGenes, ablHumansIn Situ Hybridization, FluorescenceKaryotypingLeukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeMetaphaseReverse Transcriptase Polymerase Chain Reaction

Identifiers

PMID15481444
OpenAlexW2040071290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.